Trials / Completed
CompletedNCT01242722
Evaluation of Left Ventricular Autothreshold, Phase Two
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will collect data, from an implanted Cardiac Resynchronization Therapy-Defibrillator (CRT-D) device, to further evaluate a new feature for future heart failure devices.
Detailed description
ELEVATE 2.0 is an acute, prospective, multi-center, feasibility study randomized within patient test sequence and pulse width, designed to characterize the performance of the Left Ventricular Auto Threshold (LVAT) feature.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CRT-D | Cardiac pacing via a pulse generator and implanted intracardiac leads |
Timeline
- Start date
- 2010-11-01
- Primary completion
- 2011-03-01
- Completion
- 2011-03-01
- First posted
- 2010-11-17
- Last updated
- 2012-10-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01242722. Inclusion in this directory is not an endorsement.